Morgan Stanley Raises Price Target on Glaukos to $120 From $100, Keeps Equalweight Rating
Morgan Stanley Lowers Price Target on Embecta to $12 From $13, Maintains Underweight Rating
Piper Sandler Sticks to Their Hold Rating for Digi International (DGII)
Piper Sandler Sticks to Its Hold Rating for CommVault Systems (CVLT)
Cactus (WHD) Gets a Hold From Piper Sandler
HC Wainwright & Co. Reiterates Buy on KalVista Pharma, Maintains $20 Price Target
Analysts Offer Insights on Technology Companies: Axcelis Technologies (ACLS) and ServiceNow (NOW)
ChromaDex Analyst Ratings
Morgan Stanley Cuts Price Target on Alphatec Holdings to $16 From $19, Maintains Overweight Rating
Inovio Pharmaceuticals Analyst Ratings
HC Wainwright & Co. Reiterates Neutral on Inovio Pharmaceuticals, Maintains $15 Price Target
Tenable Holdings Analyst Ratings
Buy Rating Affirmed for Chromadex on Niagen+ Launch and Market Potential
Buy Rating on KalVista Pharmaceuticals: Sebetralstat Poised to Transform HAE Treatment Landscape
Buy Rating Affirmed: Braze's Strategic Initiatives and Market Share Gains Fuel Growth Prospects
Montrose Environmental Gr Analyst Ratings
Morgan Stanley Downgrades Staar Surgical to Underweight, Lowers Price Target to $37
Staar Surgical Analyst Ratings
Rocket Lab USA Analyst Ratings
Semtech Analyst Ratings